Infliximab-induced discoid lupus erythematosus

Lupus

Volumn 22, Issue 5, 2013, Pages 515-518

  Cemil, B C ^a   Atas, H ^a   Canpolat, F ^a   Akca, Y ^b   Sasmaz, R ^a  

^a DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b MINISTRY OF HEALTH   (Turkey)

Author keywords

Anti tumor necrosis factor therapies; lupus syndrome; rheumatoid arthritis

Indexed keywords

HYDROXYCHLOROQUINE; HYDROXYCHLOROQUINE SULFATE; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; METHYLPREDNISOLONE; SALAZOSULFAPYRIDINE; STEROID;

ADULT; ARTICLE; CASE REPORT; CONTACT DERMATITIS; DERMOEPIDERMAL JUNCTION; DISCOID LUPUS ERYTHEMATOSUS; DISEASE DURATION; DRUG WITHDRAWAL; EPIDERMIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATORY INFILTRATE; LUPUS LIKE SYNDROME; LYMPHOCYTIC INFILTRATION; MALE; PARAKERATOSIS; PRIORITY JOURNAL; PRURITUS; RHEUMATOID ARTHRITIS; SKIN BIOPSY; STEROID THERAPY; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; HUMANS; LUPUS ERYTHEMATOSUS, DISCOID; MALE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84875935196     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203313479423     Document Type: Article

References (19)

1. Moustou AE, Matekovits A, Dessinioti C, et al. Cutaneous side effects of anti-tumor necrosis factor biologic therapy: A clinical review. J Am Acad Dermatol 2009; 61: 486-504.
2. Exarchou SA, Voulgari PV, Markatseli TE, et al. Immunemediated skin lesions in patients treated with anti-tumour necrosis factor alpha inhibitors. Scand J Rheumatol 2009; 38: 328-331.
3. Debandt M, Vittecoq O, Descamps V, et al. Anti-TNF-alpha-induced systemic lupus syndrome. Clin Rheumatol. 2003 ; 22: 56-61
4. Takahashi H, Kaneta K, Honma M, et al. Sarcoidosis during infliximab therapy for Crohn's disease. J Dermatol 2010; 37: 471-474.
5. Spillane AP, Xia Y, Sniezek PJ. Drug-induced lupus erythematosus in a patient treated with adalumimab. J Am Acad Dermatol 2007; 56: 114-116.
6. Favalli EG, Sinigaglia L, Varenna M, et al. Drug-induced lupus following treatment with infliximab in rheumatoid arthritis. Lupus. 2002 ; 11: 753-755
7. Gupta AK, Skinner AR. A review of the use of infliximab to manage cutaneous dermatoses. J Cutan Med Surg 2004; 8: 77-89.
8. Stratigos AJ, Antoniou C, Stamathioudaki S, et al. Discoid lupus erythematosus-like eruption induced by infliximab. Clin Exp Dermatol 2004; 29: 150-153.
9. Wetter DA, Davis MD. Lupus-like syndrome attributable to antitumor necrosis factor alpha therapy in 14 patients during an 8-year period at Mayo Clinic. Mayo Clin Proc 2009; 84: 979-984.
10. Aringer M, Smolen JS. The role of tumor necrosis factor-alpha in systemic lupus erythematosus. Arthritis Res Ther 2008; 10: 202-210.
11. Pallotta P, Cianchini G, Ruffelli M, et al. Infliximab-induced lupus-like reaction in a patient with psoriatic arthritis. Rheumatology (Oxford) 2006; 45: 116-117.
12. Shakoor N, Michalska M, Harris CA, et al. Drug-induced systemic lupus erythematosus associated with etanercept therapy. Lancet 2002; 359: 579-580.
13. Brion PH, Mittal-Henkle A, Kalunian KC. Autoimmune skin rashes associated with etanercept for rheumatoid arthritis. Ann Intern Med 1999; 131: 634.
14. Misery L, Perrot JL, Gentil-Perret A, et al. Dermatological complications of etanercept therapy for rheumatoid arthritis. Br J Dermatol 2002; 146: 334-335.
15. Gonnet-Gracia C, Barnetche T, Richez C, et al. Anti-nuclear antibodies, anti-DNA and C4 complement evolution in rheumatoid arthritis and ankylosing spondylitis treated with TNF-alpha blockers. Clin Exp Rheumatol 2008; 26: 401-407.
16. Lorenz HM, Herrmann M, Winkler T, et al. Role of apoptosis in autoimmunity. Apoptosis 2000; 5: 443-449.
17. Eriksson C, Engstrand S, Sundqvist KG, et al. Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNF alpha. Ann Rheum Dis 2005; 64: 403-407.
18. Zheng L, Fisher G, Miller RE, et al. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 1995; 377: 348-351.
19. Williams EL, Gadola S, Edwards CJ. Anti-TNF-induced lupus. Rheumatology (Oxford) 2009; 48: 716-720.